Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Prospective, Multi-Center, Open Label, Randomized Controlled, Two Arm Study Evaluating Safety and Efficacy of the Permanent Polymer Zotarolimus Eluting Stent Resolute Integrity Compared to the Polymer Free Amphilimus Eluting Stent Cre8

Next Previous
Trial Profile

A Prospective, Multi-Center, Open Label, Randomized Controlled, Two Arm Study Evaluating Safety and Efficacy of the Permanent Polymer Zotarolimus Eluting Stent Resolute Integrity Compared to the Polymer Free Amphilimus Eluting Stent Cre8

Status: Recruiting
Phase of Trial: Phase IV

Latest Information Update: 15 Mar 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Sirolimus (Primary) ; Aspirin; Clopidogrel; Prasugrel; Ticagrelor; Zotarolimus
  • Indications Acute coronary syndromes; Ischaemic heart disorders
  • Focus Therapeutic Use
  • Acronyms ReCre8

Most Recent Events

  • 01 Feb 2023 Results (n=302) of Subanalysis, assessing long-term performance of two contemporary drug-eluting stents in a diabetic population, published in the Catheterization and Cardiovascular Interventions
  • 02 Jan 2019 Results published in the Circulation
  • 15 Feb 2018 Trial design published in the Catheterization and Cardiovascular Interventions

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top